We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

30 hedge funds and large institutions have $32.5M invested in Global Cord Blood Corporation in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

3% more funds holding

Funds holding: 2930 (+1)

17% less capital invested

Capital invested by funds: $39.3M → $32.5M (-$6.78M)

69% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 13

Holders
30
Holders Change
+1
Holders Change %
+3.45%
% of All Funds
0.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
13
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
$16K
ASN
27
Advisory Services Network
Georgia
$6K +$6.08K +1,140 New
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$5K
Creative Planning
29
Creative Planning
Kansas
$2K
SCP
30
Seizert Capital Partners
Michigan
-$910K -158,194 Closed
TC
31
TFS Capital
Pennsylvania
-$90K -15,656 Closed

CO Hedge Fund Activity: Q3 2016 in Review

30 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2016, worth a combined $32.5M — down 17% from $39.3M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CO positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 13 trimmed.

The largest buyer was GLG Partners, adding an estimated $570K. The largest seller was Citigroup, cutting an estimated $1.23M.

  • 30 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2016, up from 29 in Q2 2016.
  • Funds reported $32.5M of Global Cord Blood Corporation stock for Q3 2016, down 17% quarter-over-quarter.
  • 4 funds opened new Global Cord Blood Corporation positions in Q3 2016 and 2 closed out, a net change of +2 holders.
  • The largest Global Cord Blood Corporation buyer in Q3 2016 was GLG Partners, an estimated $570K added.
  • The largest Global Cord Blood Corporation seller in Q3 2016 was Citigroup, an estimated $1.23M sold.

Based on aggregated 13F filings for Q3 2016.